About Degron Therapeutics

Degron Therapeutics is a biotechnology company advancing human health by developing novel medicines using its robust molecular glue-based targeted protein degradation drug discovery platform. The company’s unique GlueXplorer® platform has created a rapidly expanding IP-protected compound library and screening system to develop a new class of small-molecule medicines that target previously undruggable disease targets. The company’s pipeline includes a growing number of preclinical compounds for oncology, inflammation, metabolic disease, and rare diseases.